Oral Ibuprofen and ductus arteriosus in premature infants: a randomized pilot study
- PMID: 17484080
- DOI: 10.1055/s-2007-976550
Oral Ibuprofen and ductus arteriosus in premature infants: a randomized pilot study
Abstract
The purpose of this study was to evaluate the feasibility of the use oral ibuprofen suspension (OIS) in the treatment of patent ductus arteriosus (PDA) in premature infants. Premature infants (</= 35 weeks) age 2 to 7 days who suffered from respiratory distress and had been diagnosed with PDA were included in this study. Color Doppler echocardiography (ECHO) was used to measure the internal ductal diameter, pressure gradient, and the ratio of left atrial to aortic root diameters (La/Ao). Infants were randomly assigned to one of two groups: group I received three doses of intravenous (IV) indomethacin (0.2 mg/kg at 12-hour intervals) and group O received an initial dose of OIS (10 mg/kg), followed by two doses of 5 mg/kg each, after 24 and 48 hours. A follow-up ECHO was done after treatment by the same pediatric cardiologist who was blinded to the assignment of the study groups. Changes in blood platelet count, hematocrit, blood urea nitrogen, and creatinine were compared between groups. In total, 78 premature infants were screened: 21 had been diagnosed with PDA. Infants in group I (n = 9) and group O (n = 12) did not differ in birthweight (1884 +/- 485 versus 1521 +/- 398 g [mean +/- SD]; P = 0.13), gestational age (32.9 +/- 1.6 versus 31.2 +/- 2.5 weeks; P = 0.07), internal diameter of PDA (2.3 +/- 0.5 versus 2.1 +/- 0.5 mm; P = 0.34), pressure gradient across PDA (12.83 +/- 6.46 versus 11.11 +/- 4.5 mm Hg; P = 0.48), and La/Ao ratio (1.26 +/- 0.21 versus 1.17 +/- 0.12; P = 0.25). Closure of PDA was achieved in 78% (seven of nine) of infants in group I and in 83% (10 of 12) of infants in group O. Comparisons of laboratory changes following treatment in group I and group O were as follows: decrease in hematocrit (-6.5 +/- 6.6 versus -1.2 +/- 4.2; P = 0.04) and in platelet count (-54 +/- 67 versus -1 +/- 53 x 10 (3)/muL; P = 0.24), and increase in blood urea nitrogen (16.4 +/- 16.4 versus 2.1 +/- 17.4 mg/dL; P = 0.06) and serum creatinine (0.12 +/- 0.22 versus -0.06 +/- 0.19 mg/dL; P = 0.13). Two infants in group I had severe pulmonary hemorrhage, whereas there were none in the group O. Oral ibuprofen could be an easy-to-administer and efficacious alternative in the treatment of PDA.
Similar articles
-
Oral ibuprofen and indomethacin for treatment of patent ductus arteriosus in premature infants: a randomized trial at Ramathibodi Hospital.J Med Assoc Thai. 2002 Nov;85 Suppl 4:S1252-8. J Med Assoc Thai. 2002. PMID: 12549803 Clinical Trial.
-
Closure of patent ductus arteriosus with oral ibuprofen suspension in premature newborns: a pilot study.Pediatrics. 2003 Nov;112(5):e354. doi: 10.1542/peds.112.5.e354. Pediatrics. 2003. PMID: 14595076
-
Oral ibuprofen in early curative closure of patent ductus arteriosus in very premature infants.Am J Perinatol. 2007 Jun;24(6):339-45. doi: 10.1055/s-2007-981853. Epub 2007 Jun 12. Am J Perinatol. 2007. PMID: 17564958
-
Clinical pharmacology of ibuprofen and indomethacin in preterm infants with patent ductus arteriosus.Curr Pediatr Rev. 2014;10(3):216-37. Curr Pediatr Rev. 2014. PMID: 25088343 Review.
-
[Ibuprofen--a new application for pharmacological closure of patent ductus arteriosus in preterm infants. Preliminary report].Med Wieku Rozwoj. 2000;4(2 Suppl 3):65-71. Med Wieku Rozwoj. 2000. PMID: 11328971 Review. Polish.
Cited by
-
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.Cochrane Database Syst Rev. 2018 Sep 28;9(9):CD003481. doi: 10.1002/14651858.CD003481.pub7. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2020 Feb 11;2:CD003481. doi: 10.1002/14651858.CD003481.pub8. PMID: 30264852 Free PMC article. Updated.
-
Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.Cochrane Database Syst Rev. 2020 Feb 11;2(2):CD003481. doi: 10.1002/14651858.CD003481.pub8. Cochrane Database Syst Rev. 2020. PMID: 32045960 Free PMC article.
-
Heterogeneity in treatment response for patent ductus arteriosus: a meta-analysis.Eur J Pediatr. 2025 Apr 16;184(5):300. doi: 10.1007/s00431-025-06130-8. Eur J Pediatr. 2025. PMID: 40240526
-
Association of Placebo, Indomethacin, Ibuprofen, and Acetaminophen With Closure of Hemodynamically Significant Patent Ductus Arteriosus in Preterm Infants: A Systematic Review and Meta-analysis.JAMA. 2018 Mar 27;319(12):1221-1238. doi: 10.1001/jama.2018.1896. JAMA. 2018. PMID: 29584842 Free PMC article.
-
Patent ductus arteriosus: indomethacin, Ibuprofen, surgery, or no treatment at all?J Pediatr Pharmacol Ther. 2009 Jan;14(1):4-9. doi: 10.5863/1551-6776-14.1.4. J Pediatr Pharmacol Ther. 2009. PMID: 23055885 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical